UCFA
BNTX icon

United Capital Financial Advisors’s BioNTech BNTX Stock Holding History

United Capital Financial Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,858
Closed -$1.51M – 1165
2021
Q4 		$1.51M Buy
5,858
+111
+2% +$30.4K 0.01% 594
2021
Q3 		$1.57M Buy
+5,747
New +$1.83M 0.01% 572

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

United Capital Financial Advisors's BNTX Position: Q1 2022 in Review

United Capital Financial Advisors sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 5,858 shares — an estimated $1.51M sold.

United Capital Financial Advisors first reported a position in BNTX in Q3 2021 and held it in 2 quarters. The position peaked at $1.57M in Q3 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

  • United Capital Financial Advisors reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
  • United Capital Financial Advisors sold 5,858 BioNTech shares in Q1 2022, an estimated $1.51M.
  • United Capital Financial Advisors first reported a position in BioNTech in Q3 2021 and held it in 2 quarters.
  • United Capital Financial Advisors's BioNTech position peaked at $1.57M in Q3 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on United Capital Financial Advisors's 13F filing for Q1 2022, filed 16 May 2022.